Cytosorbents (CTSO) Balance Sheet: Assets & Liabilities

Cytosorbents (CTSO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cytosorbents reported total assets of $44.18M and total liabilities of $38.28M. Shareholders' equity was $5.90M, down 46.9% from $11.11M a year earlier. Total debt stood at $17.21M against $6.25M in cash and short-term investments, a net debt position of $10.96M. That puts debt-to-equity at 2.92, compared with 2.42 a year earlier.

Cytosorbents Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cytosorbents Corporation (CTSO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	6.25	3.28	3.28	14.13	22.14	52.14	71.42	12.23	22.37	17.32
Cash & Short-Term Investments	6.25	3.28	3.28	14.13	22.14	52.14	71.42	12.23	22.37	17.32
Accounts Receivable	7.55	7.32	7.32	6.06	5.66	4.52	5.16	4.47	3.94	2.21
Inventory	5.28	2.73	2.73	3.68	3.46	4.77	2.67	2.11	0.83	0.80
Other Current Assets	1.55	8.27	8.27	1.83	2.49	2.87	3.20	2.09	1.12	0.42
Total Current Assets	20.63	21.60	21.60	25.70	33.76	64.30	82.45	20.90	28.26	20.74
Non-Current Assets
Property, Plant & Equipment (Net)	18.75	20.51	20.51	22.12	23.35	18.57	3.15	3.00	1.73	1.40
Long-Term Investments	1.52	0.00	-	1.48	1.73	1.94	0.13	0.12	0.13	0.12
Goodwill	3.23	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	3.23	3.75	3.72	3.91	4.39	4.70	4.22	3.36	2.63	1.84
Other Non-Current Assets	1.58	1.51	1.53	-3.65	0.00	1.69	0.00	3.49	0.00	0.12
Total Non-Current Assets	23.55	25.77	25.77	27.56	29.47	25.22	7.50	6.48	4.48	3.36
Total Assets	44.18	47.37	47.37	53.26	63.23	89.52	89.95	27.38	32.75	24.10
Current Liabilities
Accounts Payable	2.87	3.34	3.34	3.80	1.66	3.85	2.47	2.04	1.49	1.24
Short-Term Debt	0.54	0.45	-	2.87	0.11	0.57	0.45	2.52	1.05	4.00
Current Portion of Long-Term Debt	-	-	-	2.50	-	-	-	-	-	-
Accrued Liabilities	5.06	-	6.03	7.36	7.95	7.11	7.14	-	-	-
Deferred Revenue	0.33	0.42	0.42	1.38	1.52	2.16	1.03	0.16	0.00	0.01
Other Current Liabilities	0.91	5.61	0.87	6.43	6.41	7.58	6.20	4.81	4.20	2.14
Total Current Liabilities	9.71	9.82	9.83	14.55	9.71	13.69	10.15	9.94	6.54	7.85
Non-Current Liabilities
Long-Term Debt	16.67	26.44	14.00	15.44	18.14	13.25	0.58	14.03	10.35	5.99
Deferred Tax Liabilities	0.00	0.00	-	3.71	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	28.57	26.44	26.44	15.44	18.14	13.25	0.58	14.03	9.27	5.99
Total Liabilities	38.28	36.26	36.27	29.99	27.86	26.94	10.73	23.97	15.81	13.84
Stockholders' Equity
Common Stock	0.06	0.05	0.06	0.05	0.04	0.04	0.04	0.03	0.03	0.03
Retained Earnings	-312.21	-304.01	-304.01	-282.51	-254.00	-221.19	-196.63	-188.79	-169.52	-152.31
Accumulated Other Comprehensive Income	-2.98	4.25	4.25	0.53	2.33	0.53	-1.73	0.53	0.29	-0.36
Additional Paid-in Capital	321.02	310.81	310.81	305.20	287.00	283.19	277.53	191.65	186.14	163.27
Shares Outstanding	3.14	-	2.76	2.73	2.19	43.69	-	-	-	-
Total Stockholders' Equity	5.90	11.11	11.11	23.28	35.37	62.58	79.22	3.42	16.93	10.26
Total Liabilities & Equity	44.18	47.37	47.37	53.26	63.23	89.52	89.95	27.38	32.75	24.10

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cytosorbents Balance Sheet

How much debt does Cytosorbents have?

Cytosorbents had total debt of $17.21M as of Dec 31, 2025, against $6.25M in cash and short-term investments. Its debt-to-equity ratio was 2.92. Total debt was $26.89M a year earlier.

What are Cytosorbents's total assets?

Cytosorbents reported total assets of $44.18M as of Dec 31, 2025, down 6.7% from $47.37M a year earlier. Total liabilities were $38.28M.

What is Cytosorbents's shareholders' equity?

Cytosorbents's shareholders' equity was $5.90M as of Dec 31, 2025, or about $1.88 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition